Compare LSCC & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSCC | ACHC |
|---|---|---|
| Founded | 1983 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 1.3B |
| IPO Year | 1989 | N/A |
| Metric | LSCC | ACHC |
|---|---|---|
| Price | $76.39 | $14.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $76.18 | $24.38 |
| AVG Volume (30 Days) | 2.0M | ★ 3.5M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.20 | ★ 1.18 |
| Revenue | $494,889,000.00 | ★ $3,265,548,000.00 |
| Revenue This Year | $4.23 | $6.50 |
| Revenue Next Year | $21.23 | $4.38 |
| P/E Ratio | $381.27 | ★ $12.11 |
| Revenue Growth | N/A | ★ 4.58 |
| 52 Week Low | $34.69 | $12.63 |
| 52 Week High | $81.23 | $47.08 |
| Indicator | LSCC | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 59.70 | 34.32 |
| Support Level | $74.88 | $13.60 |
| Resistance Level | $79.97 | $14.70 |
| Average True Range (ATR) | 3.11 | 0.95 |
| MACD | 0.59 | 0.11 |
| Stochastic Oscillator | 69.49 | 32.02 |
Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.